{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-001", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 64-year-old man with metastatic hemangiopericytoma presents with refractory hypoglycemia (glucose 28 mg/dL) despite 20% dextrose infusion at 100 mL/hour. Labs show insulin <2 \u03bcIU/mL, C-peptide 0.1 ng/mL, IGF-2 850 ng/mL (normal 50-200), and IGF-2:IGF-1 ratio 12:1. Which immediate pharmacologic intervention is most likely to achieve euglycemia within 24 hours?\nOptions:\nA. Continuous hydrocortisone infusion 10 mg/hour\nB. Recombinant IGF-1 40 mg subcutaneously twice daily\nC. Diazoxide 300 mg orally three times daily\nD. Octreotide 200 \u03bcg subcutaneously three times daily\nE. Glucagon 2 mg intramuscularly every 4 hours\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-002", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 42-year-old man with MEN1 syndrome (germline MEN1 c.628_631del) is found to have a 2.8 cm duodenal gastrinoma with 3 regional periduodenal lymph node metastases on Ga-68 DOTATATE PET/CT. Serum gastrin is 2,200 pg/mL with gastric pH <2. He has no pancreatic lesions. What is the optimal surgical management?\nOptions:\nA. A) Whipple pancreaticoduodenectomy with pylorus preservation\nB. B) Pancreas-preserving duodenectomy with regional lymphadenectomy\nC. C) Endoscopic submucosal dissection of the duodenal tumor\nD. D) Long-acting octreotide 30 mg monthly without surgery\nE. E) Tumor enucleation through duodenotomy only\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-003", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 59-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and weight loss. HRCT demonstrates upper lobe-predominant pleural thickening, subpleural consolidation, and traction bronchiectasis with severe volume loss. Surgical lung biopsy shows dense subpleural fibrosis with prominent elastic fiber deposition and minimal inflammation, extending into the pleura. Which histopathologic finding most strongly differentiates this from usual interstitial pneumonia?\nOptions:\nA. Fibroblast foci within alveolar walls\nB. Honeycomb change with mucin-filled cysts\nC. Presence of intra-alveolar fibroblastic plugs\nD. Elastosis involving visceral pleura and subpleural parenchyma\nE. Patchy temporally heterogeneous fibrosis\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-004", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 35-year-old woman with CFH p.Arg1215Gln mutation undergoes deceased donor kidney transplantation. On postoperative day 7, she develops rising creatinine (3.4 mg/dL), thrombocytopenia (45,000/\u03bcL), schistocytes, and hemolysis. Eculizumab 900 mg weekly was started preemptively on day 0. Platelets normalize by day 10 but creatinine continues to rise to 4.8 mg/dL. What is the next step?\nOptions:\nA. A) Increase eculizumab dose to 1,200 mg weekly\nB. B) Initiate daily plasma exchange with fresh frozen plasma\nC. C) Switch to ravulizumab 3,600 mg maintenance dose\nD. D) Measure eculizumab trough level and CH50 activity\nE. E) Proceed with transplant nephrectomy\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-005", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 28-year-old man is day +45 after matched unrelated donor allogeneic stem cell transplant for AML in CR1. He develops new hypertension (BP 165/100 mmHg), proteinuria (3.2 g/day), rising LDH (850 U/L), hemolysis, and thrombocytopenia. ADAMTS13 activity is 45%. Tacrolimus was stopped 14 days ago for rising creatinine. What is the appropriate therapy?\nOptions:\nA. A) Eculizumab 900 mg weekly IV\nB. B) High-dose methylprednisolone 1 g IV x3 days plus plasma exchange\nC. C) Rituximab 375 mg/m2 weekly for 4 doses\nD. D) Resume tacrolimus and target level 8-10 ng/mL\nE. E) Supportive care with aggressive blood pressure control only\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-006", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 14-year-old girl with chronic atypical neutrophilic dermatosis, lipodystrophy, and recurrent fevers (CANDLE syndrome) has persistent inflammatory lesions and fevers despite anakinra 100 mg daily and canakinumab 150 mg monthly. Genetic testing confirms PSMB8 c.224C>T mutation. What is the next therapy?\nOptions:\nA. A) High-dose prednisone 1 mg/kg/day\nB. B) Baricitinib 4 mg daily (JAK1/2 inhibitor)\nC. C) Tocilizumab 8 mg/kg IV monthly\nD. D) Thalidomide 100 mg nightly\nE. E) Allogeneic stem cell transplant\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-007", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: An 8-year-old boy presents with recurrent fevers, livedo racemosa, recurrent lacunar strokes, and vasculitic neuropathy. Laboratory studies show low IgM, elevated IgA, and negative ANCA. Genetic testing confirms biallelic loss-of-function mutations in ADA2. Which biologic therapy is most effective for this condition?\nOptions:\nA. A) High-dose systemic glucocorticoids\nB. B) Intravenous cyclophosphamide\nC. C) Etanercept\nD. D) Anakinra\nE. E) Rituximab\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-008", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 38-year-old man from Vietnam with chronic mucocutaneous candidiasis is found to have STAT1 gain-of-function c.821T>C mutation. He presents with disseminated umbilicated papular skin lesions, hepatosplenomegaly, and fevers. Skin biopsy shows intracellular yeast forms with central septation. What is optimal therapy?\nOptions:\nA. A) Liposomal amphotericin B 5 mg/kg/day alone for 14 days\nB. B) Voriconazole 6 mg/kg IV q12h then 4 mg/kg maintenance\nC. C) Liposomal amphotericin B induction then itraconazole maintenance plus ruxolitinib 10 mg BID\nD. D) Caspofungin 70 mg loading then 50 mg daily\nE. E) Fluconazole 800 mg loading then 400 mg daily\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-009", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 72-year-old woman with metastatic melanoma on combination ipilimumab/nivolumab develops six watery stools daily. Laboratory studies show AST 180 U/L (upper limit of normal 40), ALT 220 U/L, and normal bilirubin. Colonoscopy reveals ulcerative colitis-like changes. What is the next step in management?\nOptions:\nA. Start prednisone 1 mg/kg plus infliximab 5 mg/kg\nB. Start prednisone 1 mg/kg plus vedolizumab 300 mg\nC. Start prednisone 1 mg/kg; if no improvement in 3-5 days add vedolizumab\nD. Hold immunotherapy and observe\nE. Start mycophenolate mofetil 1 g twice daily\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
{"custom_id": "ABMS20260101_kimi-k2-thinking_p03__ABMS20260101_kimi-k2-thinking_p03-010", "method": "POST", "url": "/v1/responses", "body": {"model": "gpt-5.1-2025-11-13", "input": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 42-year-old woman with lifelong idiopathic anaphylaxis, chronic urticaria, joint hypermobility, and baseline serum tryptase of 35 ng/mL is found to have heterozygous TPSAB1 copy number gain (\u03b1-tryptasemia). Symptoms persist despite high-dose cetirizine 40 mg daily and omalizumab 300 mg monthly. What is next therapy?\nOptions:\nA. A) Increase omalizumab to 600 mg monthly\nB. B) Prophylactic prednisone 10 mg daily\nC. C) Cromolyn sodium 200 mg QID\nD. D) Ketotifen 2 mg BID (mast cell stabilizer)\nE. E) Allergen immunotherapy based on skin testing\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E).", "reasoning": {"effort": "high"}}}
